{"retracted":false,"update":{"timestamp":1381795200000,"doi":"10.1371/annotation/67550546-cacf-4063-8d62-d165da14ca61","type":"correction"},"doi":"10.1371/journal.pone.0067177","journal":"PLoS ONE","publisher":"Public Library of Science (PLoS)","title":"Correction: Two Doses of Candidate TB Vaccine MVA85A in Antiretroviral Therapy (ART) Na√Øve Subjects Gives Comparable Immunogenicity to One Dose in ART+ Subjects"}
